Genetic and autoimmune predispositions to fulminant viral hepatitis in children
Abstract
Fulminant viral hepatitis (FVH) in children is a rare but often fatal form of acute liver failure occurring in the absence of preexisting liver disease. Its exceptional incidence during otherwise common viral infections, including hepatitis A virus (HAV), hepatitis B virus (HBV), and herpes simplex virus (HSV), supports a decisive role for host susceptibility. Recent advances in human immunogenetics delineate two major, mechanistically distinct pathways to pediatric FVH. The first reflects failure of immune regulation, culminating in excessive IFN-γ-driven inflammation and immune-mediated hepatocellular necrosis. Autosomal recessive IL-18BP and IL-10RB deficiencies exemplify this mechanism, in which disruption of key regulatory checkpoints permits uncontrolled activation of cytotoxic lymphocytes and macrophage-dependent immunopathology, particularly in the context of HAV infection. The second pathway involves impaired intrinsic antiviral defense, most prominently through neutralizing autoantibodies against type I interferons, which phenocopy genetic defects of IFN-I signaling and are strongly associated with HSV-triggered FVH; in this setting, inadequate early antiviral control enables unchecked hepatic replication with extensive cytopathic damage. Finally, syndromic hyperinflammatory disorders, including familial hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease, broaden the spectrum of immune predisposition in which fulminant hepatitis may arise. Together, these discoveries redefine pediatric FVH as an immunopathological syndrome and provide a framework for targeted genetic and serologic diagnosis and for mechanism-based interventions aimed at improving survival.
Related
- Veillonella dispar triggers dual-hits in the pathogenesis of autoimmune hepatitis and primary biliary cholangitis via testosterone depletion-BAFF-B cell axis and Th17 cell activation
- Antigen specificity and inflammatory amplification in autoimmune hepatitis
- Case Report: Acute liver failure in systemic lupus erythematosus with autoimmune hepatitis–primary biliary cholangitis overlap: a belimumab-containing regimen and longitudinal follow-up
- Macrophage-derived IL-27 sustains autoreactive CD8+ cytotoxic T cells in autoimmune hepatitis
- Assessing the relationship between chronic aflatoxin exposure and hepatitis B virus immune protection in a population of children receiving nutritional support in Rwanda
BibTeX
@article{bousfiha2026genetic,
title = {{Genetic and autoimmune predispositions to fulminant viral hepatitis in children}},
author = {Mohamed Bousfiha and Dalal Ben Sabbahia and Emmanuelle Jouanguy and Jean-Laurent Casanova and Jalila El Bakkouri and Ahmed Aziz Bousfiha and Naima Amenzoui},
journal = {Frontiers in Immunology},
year = {2026},
month = aug,
doi = {10.3389/fimmu.2026.1858895},
url = {https://hal.science/hal-05863784v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Genetic and autoimmune predispositions to fulminant viral hepatitis in children
AU - Mohamed Bousfiha
AU - Dalal Ben Sabbahia
AU - Emmanuelle Jouanguy
AU - Jean-Laurent Casanova
AU - Jalila El Bakkouri
AU - Ahmed Aziz Bousfiha
AU - Naima Amenzoui
PY - 2026
DA - 2026/08/07
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1858895
UR - https://hal.science/hal-05863784v1
AB - Fulminant viral hepatitis (FVH) in children is a rare but often fatal form of acute liver failure occurring in the absence of preexisting liver disease. Its exceptional incidence during otherwise common viral infections, including hepatitis A virus (HAV), hepatitis B virus (HBV), and herpes simplex virus (HSV), supports a decisive role for host susceptibility. Recent advances in human immunogenetics delineate two major, mechanistically distinct pathways to pediatric FVH. The first reflects failure of immune regulation, culminating in excessive IFN-γ-driven inflammation and immune-mediated hepatocellular necrosis. Autosomal recessive IL-18BP and IL-10RB deficiencies exemplify this mechanism, in which disruption of key regulatory checkpoints permits uncontrolled activation of cytotoxic lymphocytes and macrophage-dependent immunopathology, particularly in the context of HAV infection. The second pathway involves impaired intrinsic antiviral defense, most prominently through neutralizing autoantibodies against type I interferons, which phenocopy genetic defects of IFN-I signaling and are strongly associated with HSV-triggered FVH; in this setting, inadequate early antiviral control enables unchecked hepatic replication with extensive cytopathic damage. Finally, syndromic hyperinflammatory disorders, including familial hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease, broaden the spectrum of immune predisposition in which fulminant hepatitis may arise. Together, these discoveries redefine pediatric FVH as an immunopathological syndrome and provide a framework for targeted genetic and serologic diagnosis and for mechanism-based interventions aimed at improving survival.
SN - 1664-3224
SN - 1664-3224
ER -